Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Diabesity: The pandemic impacting populations around the globe
Diabesity: Global Epidemic Lede

Diabesity: The pandemic impacting populations around the globe

Obesity and diabetes rates are increasing so much that there’s a term for it: diabesity. Here’s what you should know about this worldwide health crisis.

They’re sobering statistics. Between 1980 and 2013, the number of overweight and obese people grew from 857 million to 2.1 billion globally. Today, over a quarter of those who are obese also have type 2 diabetes.
On their own, obesity and diabetes can lead to serious health complications—but when combined, “diabesity,” as experts are calling the simultaneous rise in both conditions, can really leave a detrimental mark on the health of people in nearly every corner of the globe.

As we mark World Diabetes Day on November 14, see how Johnson & Johnson is lending its support to help with the health crisis—and what steps you can take to be your best, healthy self.

Diabesity: A Global Pandemic Infographic-compressed.jpg

Here’s how you can learn more about the growing impact of diabetes and obesity around the world.

More from Johnson & Johnson

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

What is inflammation?

Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.

What is IL-23?

This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.